Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Personalis Extends Collaboration with Merck and Moderna to Advance Cancer Care

Dec 19, 2024•over 1 year ago

Contract Type

partnership

FremontBiotechnologyHealth Care

Description

Personalis, Inc. has extended its collaboration with long-time collaborators Merck and Moderna through agreements that accelerate the advancement of the company’s business strategy. This includes an investment from Merck and a multi-year extension with Moderna to utilize Personalis’ ImmunoID NeXT Platform® and technology for V940/mRNA-4157, an investigational individualized neoantigen therapy (INT), being jointly developed by Merck and Moderna.

Company Information

Company

Personalis and Tempus AI

Location

Fremont, California, United States

About

Personalis, Inc. and Tempus AI, Inc. have expanded their commercial relationship to bring ultra-sensitive MRD testing to market and have agreed to accelerate their efforts, collaborating for broad patient adoption in breast and lung cancers, and for immunotherapy monitoring across all solid tumors.

Predictive Intelligence
Strategic

ML-powered predictions for Personalis and Tempus AI's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.